Plain-English translation of NCT06163807 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry that tracks people with asthma over three years to better understand their condition and how treatments help. Researchers will collect information about your asthma control, any flare-ups you experience, and your response to medications—including newer biologic treatments like dupilumab, mepolizumab, benralizumab, reslizumab, and omalizumab. The goal is to learn what works best for different types of asthma and identify patterns that help predict treatment success.
Asthma affects people differently, and doctors don't yet fully understand why some patients respond well to certain treatments while others don't. This study aims to close that gap by collecting real-world information about asthma control, inflammatory markers in the blood, and how patients do over time—helping doctors personalize treatment recommendations in the future.
You likely qualify if…
You likely don't qualify if…
You will visit your asthma clinic regularly over three to five years. At these visits, doctors will perform routine lung function tests, ask about your asthma symptoms and medication use, and collect blood samples to measure inflammatory markers. If you are starting or already receiving a biologic medication, researchers will track how well it works and any side effects. All of this happens as part of your regular care—there are no experimental treatments to try, but your information contributes to a large database helping researchers understand asthma better.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Spain